Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Riemer TG"'
Publikováno v:
Polish archives of internal medicine [Pol Arch Intern Med] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.
Autor:
Basedow LA; Department of Psychology, Clinical Psychology and Psychotherapy, Philipps-Universität Marburg, Gutenbergstraße 18, 35037, Marburg, Germany. lukas.basedow@uni-marburg.de., Majić T; Psychedelic Substances Research Group, Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Psychiatry und Neurosciences, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Hafiz NJ; Institute for Educational Quality Improvement (IQB), Humboldt-Universität zu Berlin, Berlin, Germany., Algharably EAE; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany., Kreutz R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany., Riemer TG; Psychedelic Substances Research Group, Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 26; Vol. 14 (1), pp. 14782. Date of Electronic Publication: 2024 Jun 26.
Autor:
Lense XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany. Xenija.Lense@umm.de., Hiemke C; Clinic of Psychiatry and Psychotherapy, University of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany., Funk CSM; Institute of Clinical Pharmacology and Toxicology, Charité University, Berlin, Germany., Havemann-Reinecke U; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Clinic of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany., Hefner G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Vitos Clinic of Forensic Psychiatry, Eltville, Germany., Menke A; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Psychosomatic Clinic Medical Park Chiemseeblick, Bernau a. Chiemsee, Germany.; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Mössner R; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany., Riemer TG; Institute of Clinical Pharmacology and Toxicology, Charité University, Berlin, Germany., Scherf-Clavel M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany., Schoretsanitis G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Zürich, Zürich, Switzerland., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany., Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2024 Feb; Vol. 241 (2), pp. 275-289. Date of Electronic Publication: 2023 Oct 19.
Autor:
Bittner N; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany. nadine.bittner@charite.de., Funk CSM; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Schmidt A; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Bermpohl F; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Brandl EJ; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Algharably EEA; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Kreutz R; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany., Riemer TG; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117, Berlin, Germany. thomas.riemer@charite.de.; Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115, Berlin, Germany. thomas.riemer@charite.de.
Publikováno v:
Drugs & aging [Drugs Aging] 2023 Nov; Vol. 40 (11), pp. 953-964. Date of Electronic Publication: 2023 Sep 08.
Autor:
Wesner K; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Hiemke C; Department of Psychiatry and Psychotherapy, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Bergemann N; Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany.; Department of Biological and Clinical Psychology, University of Trier, Trier, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Egberts KM; ); Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Fekete S; ); Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Gerlach M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Havemann-Reinecke U; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Lense XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Riemer TG; Charité-Medical University of Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.; Behavioral Health Pavilion, Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, and Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, New York.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Uhr M; Clinical Laboratory, Max Planck Institute of Psychiatry, Munich, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Zernig G; Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Hart XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'.; Corresponding Author: Xenia M. Hart, Central Institute of Mental Health Mannheim; J5, 68159 Mannheim (xenia.hart@zi-mannheim.de).
Publikováno v:
The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Jul 19; Vol. 84 (5). Date of Electronic Publication: 2023 Jul 19.
Autor:
Hafiz NJ; Department of Clinical Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Lohse A; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Haas R; Department of Clinical Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Hannover, Germany., Reiche S; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Sedlaczek L; Department of Clinical Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Brandl EJ; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany., Riemer TG; Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Psychiatry and Psychotherapy, Berlin, Germany.; Charité - Universitätsmedizin Berlin Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
Publikováno v:
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists [Arch Clin Neuropsychol] 2023 Jan 21; Vol. 38 (1), pp. 25-36.
Autor:
Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany. xenia.hart@zi-mannheim.de.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany. xenia.hart@zi-mannheim.de., Hiemke C; Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Eichentopf L; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany., Lense XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany., Clement HW; Department of Child and Adolescent Psychiatry, University of Freiburg, Freiburg, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Conca A; Sanitario Di Bolzano, Servizio Psichiatrico del Comprensorio, Bolzano, Italy.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Faltraco F; Department of Psychiatry and Psychotherapy, University of Rostock, Rostock, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Florio V; Sanitario Di Bolzano, Servizio Psichiatrico del Comprensorio, Bolzano, Italy., Grüner J; Department of Child and Adolescent Psychiatry, University of Freiburg, Freiburg, Germany., Havemann-Reinecke U; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Molden E; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway., Paulzen M; Department of Psychiatry, Psychotherapy and Psychosomatics, Alexianer Hospital Aachen, Aachen, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Psychiatric University Hospital Zurich, Zurich, Switzerland.; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Zucker School of Medicine at Northwell/Hofstra, Department of Psychiatry, Hempstead, NY, USA.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany., Riemer TG; Institute of Clinical Pharmacology and Toxicology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.; Arbeitsgemeinschaft Für Neuropsychopharmakologie Und Pharmakopsychiatrie (AGNP), Work group Therapeutic Drug Monitoring, München, Germany.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2022 Nov; Vol. 239 (11), pp. 3377-3391. Date of Electronic Publication: 2022 Oct 05.
Autor:
Eichentopf L; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany., Hiemke C; Department of Psychiatry and Psychotherapy, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany., Conca A; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry, Central Hospital, Sanitary Agency of South Tyrol, Bolzano, Italy., Engelmann J; Department of Psychiatry and Psychotherapy, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany., Gerlach M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany., Havemann-Reinecke U; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany., Hefner G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Vitos Clinic for Forensic Psychiatry, Forensic Psychiatry, Eltville, Germany., Florio V; Department of Psychiatry, Comprensorio Sanitario di Bolzano, Bolzano, Italy., Kuzin M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Clienia Schlössli AG, Psychiatric and Psychotherapeutic Private Clinic, Academic Teaching Hospital of the University of Zurich, Oetwil am See, Switzerland., Lieb K; Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Mainz, Germany., Reis M; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Chemistry and Pharmacology, Skåne University Hospital, Lund, Sweden., Riemer TG; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Serretti A; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Schoretsanitis G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.; Department of Psychiatry, Behavioral Health Pavilion, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, NY, United States.; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, United States., Zernig G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.; Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany., Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group 'Therapeutic Drug Monitoring', Nürnberg, Germany.
Publikováno v:
Frontiers in psychiatry [Front Psychiatry] 2022 Oct 17; Vol. 13, pp. 972141. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Autor:
Funk CSM; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Hart XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Hiemke C; Department of Psychiatry and Psychotherapy, University Medical Center, Mainz, Germany., Elsner B; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany., Kreutz R; Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Riemer TG; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
Publikováno v:
Frontiers in psychiatry [Front Psychiatry] 2022 Feb 21; Vol. 13, pp. 826138. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).
Autor:
Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M
Publikováno v:
Cardiovascular research [Cardiovasc Res] 2021 Sep 28; Vol. 117 (11), pp. 2394.